p27 Expression in Inflammatory Bowel Disease-Associated Neoplasia: Further Evidence of a Unique Molecular Pathogenesis
- 30 November 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (5) , 1511-1518
- https://doi.org/10.1016/s0002-9440(10)65466-1
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA5P01CA44704–10)
This publication has 55 references indexed in Scilit:
- Differentiation-Related Mechanisms Which Suppress DNA ReplicationExperimental Cell Research, 1999
- Interleukin-6 Induces G1Arrest through Induction of p27Kip1, a Cyclin-Dependent Kinase Inhibitor, and Neuron-like Morphology in LNCaP Prostate Tumor CellsBiochemical and Biophysical Research Communications, 1999
- Colorectal cancer in inflammatory bowel diseaseDiseases of the Colon & Rectum, 1999
- p27kip1 acts as a downstream effector of and is coexpressed with the β1C integrin in prostatic adenocarcinomaJournal of Clinical Investigation, 1999
- Cancer Cell CyclesScience, 1996
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Cell, 1996
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996
- Cell Cycle and Cancer: Critical Events at the G1 Restriction PointCritical Reviews™ in Oncogenesis, 1996
- APC mutations occur early during colorectal tumorigenesisNature, 1992
- Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma.Environmental Health Perspectives, 1991